Silymarin 140 mg (Livermarin 140 mg)
An adjunctive therapy in the treatment of accute/chronic inflammatory diseases of the liver or hepatic cirrhosis and various liver disorders including acute and chronic hepatitis, cirrhosis, fatty liver disease, Infectious hepatitis, alcohol-induced liver disease
Highlight
Protect liver cells from chemicals and drugs that are harmful. Apparently, it also has an antioxidant and anti-inflammatory impact and improves glycemic control in patients with concomitant diabetes
Description
17,659 view
0
Benefit
Silymarin is indicated as adjunctive therapy in the treatment of accute/chronic inflammatory diseases of the liver or hepatic cirrhosis and various liver disorders including
- Acute and chronic hepatitis
- cirrhosis
- fatty liver disease
- Infectious hepatitis
- alcohol-induced liver disease
Detail
Silymarin is an active concept obtained from milk thistle seed (Silybum marianum). It could protect liver cells from chemicals and drugs that are harmful. Apparently, it also has an antioxidant and anti-inflammatory impact. Clinically, silymarin reduces liver dysfunction, may reduce liver-related mortality in patients with cirrhosis and improves glycemic control in patients with concomitant diabetes
- Livermarin (Silymarin 140 mg)
- Livermarin (Silymarin 140 mg)